Bol.

Sulfasol Vet

Drug Class: Antibiotic

Manufacturer: Acme Laboratories LTD.

Basic information

Generic Drug

Route of Administration

PO

Strength / Concentration

5 gm/bolus

Presentation and price

5 gm

12 Taka

Dose and dosage

Cattle

First day: 1bolus/25-50kg body weight 

From 2nd day: 1bolus/50-100kg body weight for 4 days.

For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.

Buffalo

First day: 1bolus/25-50kg body weight 

From 2nd day: 1bolus/50-100kg body weight for 4 days.

For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.

Horse

First day: 1bolus/25-50kg body weight 

From 2nd day: 1bolus/50-100kg body weight for 4 days.

For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.

Goat

First day: 1bolus/25kg body weight 

From 2nd day: 1bolus/50kg body weight for 4 days.

For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.

Sheep

First day: 1bolus/25kg body weight 

From 2nd day: 1bolus/50kg body weight for 4 days.

For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.


Applications: Pneumonia, bronchitis, Hemorrhagic Septicemia, Actinobacillosis, infection of urogenital system, Metritis, Retention of placenta, Abscess, Gastrointestinal infection, Diarrhea, Dysentery , Enteritis, salmonellosis, Septicemia
-----

Prevention of secondary bacterial infection

Avoid In: Hypersensitivity

Sulfadimidine is a short-acting sulfonamide. It interferes with the synthesis of nucleic acids in sensitive organisms by blocking the conversion of p-aminobenzoic acid (PABA) to the co-enzyme dihydrofolic acid.

Nausea, vomiting, anorexia, diarrhoea, hypersensitivity reactions, SLE, serum sickness-like syndrome, liver necrosis and hepatomegaly, myocarditis, pulmonary eosinophilia and fibrosing alveolitis, vasculitis, hypoglycaemia, hypothyroidism, neurological reactions, jaundice and kernicterus in premature neonates

Sulfadimidine has been assigned to pregnancy category C by the FDA. Sulfonamides cross the placenta. Animal studies with high oral doses of some sulfonamides have revealed an increased incidence of cleft palate and other bony abnormalities.

Because sulfonamides compete with bilirubin for binding to serum albumin, free bilirubin levels rise in the presence of sulfonamides. Neonates are, therefore, at risk for hyperbilirubinemia, jaundice, and kernicterus when sulfonamides are administered to the mother near term

Meat: 7 days

Milk: 3 days